Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer
Alterations in treatment intensity and decreased use of radiation therapy have reduced the risk of late treatment-related death in long-term survivors of childhood cancer. In the 1960s, fewer than half the children in whom cancer was diagnosed were still alive 5 years later. 1 Now, more than 83% of...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2016-03, Vol.374 (9), p.833-842 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 842 |
---|---|
container_issue | 9 |
container_start_page | 833 |
container_title | The New England journal of medicine |
container_volume | 374 |
creator | Armstrong, Gregory T Chen, Yan Yasui, Yutaka Leisenring, Wendy Gibson, Todd M Mertens, Ann C Stovall, Marilyn Oeffinger, Kevin C Bhatia, Smita Krull, Kevin R Nathan, Paul C Neglia, Joseph P Green, Daniel M Hudson, Melissa M Robison, Leslie L |
description | Alterations in treatment intensity and decreased use of radiation therapy have reduced the risk of late treatment-related death in long-term survivors of childhood cancer.
In the 1960s, fewer than half the children in whom cancer was diagnosed were still alive 5 years later.
1
Now, more than 83% of patients with a childhood cancer in the United States become 5-year survivors of the disease.
2
As a result, in 2013 it was estimated that there were more than 420,000 survivors of childhood cancer in the United States and that by the year 2020 this number would surpass 500,000.
3
Increased success in the treatment of childhood cancers has been achieved through the systematic conduct of clinical trials to assess the efficacy of multimodal approaches involving combination chemotherapy, . . . |
doi_str_mv | 10.1056/NEJMoa1510795 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1772831794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1772831794</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-a77a55ee9be39dbed40627f493b1683e193468b63af38679de8ba6c753b420373</originalsourceid><addsrcrecordid>eNp10EtLw0AUBeBBFFurS7cyIIKb6EzmlVlKaH3QKvhYuAqT5MamJJk6kxT6701pFRS8m7v5OBwOQqeUXFEi5PXj-GFmDRWUKC320JAKxgLOidxHQ0LCKOBKswE68n5B-qNcH6JBKJWkMhRDNHmGvMva0ja4bPDUtIBn1rWmKts1NrVtPrAI3sE4_NK5VbmyzmNb4HheVvnc2hzHpsnAHaODwlQeTnZ_hN4m49f4Lpg-3d7HN9Mg40K2gVHKCAGgU2A6TyHve4aq4JqlVEYMqGZcRqlkpmCRVDqHKDUyU4KlPCRMsRG63OYunf3swLdJXfoMqso0YDufUKXCiFGleU_P_9CF7VzTt9sowrQmoe5VsFWZs947KJKlK2vj1gklyWbg5NfAvT_bpXZpDfmP_l60BxdbUNc-aWBR_xP0Bew-fzM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1770399029</pqid></control><display><type>article</type><title>Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Armstrong, Gregory T ; Chen, Yan ; Yasui, Yutaka ; Leisenring, Wendy ; Gibson, Todd M ; Mertens, Ann C ; Stovall, Marilyn ; Oeffinger, Kevin C ; Bhatia, Smita ; Krull, Kevin R ; Nathan, Paul C ; Neglia, Joseph P ; Green, Daniel M ; Hudson, Melissa M ; Robison, Leslie L</creator><creatorcontrib>Armstrong, Gregory T ; Chen, Yan ; Yasui, Yutaka ; Leisenring, Wendy ; Gibson, Todd M ; Mertens, Ann C ; Stovall, Marilyn ; Oeffinger, Kevin C ; Bhatia, Smita ; Krull, Kevin R ; Nathan, Paul C ; Neglia, Joseph P ; Green, Daniel M ; Hudson, Melissa M ; Robison, Leslie L</creatorcontrib><description>Alterations in treatment intensity and decreased use of radiation therapy have reduced the risk of late treatment-related death in long-term survivors of childhood cancer.
In the 1960s, fewer than half the children in whom cancer was diagnosed were still alive 5 years later.
1
Now, more than 83% of patients with a childhood cancer in the United States become 5-year survivors of the disease.
2
As a result, in 2013 it was estimated that there were more than 420,000 survivors of childhood cancer in the United States and that by the year 2020 this number would surpass 500,000.
3
Increased success in the treatment of childhood cancers has been achieved through the systematic conduct of clinical trials to assess the efficacy of multimodal approaches involving combination chemotherapy, . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa1510795</identifier><identifier>PMID: 26761625</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Acute lymphoblastic leukemia ; Adolescent ; Age of Onset ; Anthracycline ; Astrocytoma - mortality ; Cancer ; Cancer therapies ; Child ; Child mortality ; Child, Preschool ; Children ; Children & youth ; Clinical outcomes ; Cohort Studies ; Death ; Disease Progression ; Female ; Health risk assessment ; Heart ; Hodgkin Disease - mortality ; Humans ; Incidence ; Infant ; Lymphatic leukemia ; Lymphoma ; Male ; Mortality ; Mortality - trends ; Neoplasms - mortality ; Neoplasms - therapy ; Patients ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality ; Radiation therapy ; Recurrence ; Survivors ; United States - epidemiology ; Wilms Tumor - mortality</subject><ispartof>The New England journal of medicine, 2016-03, Vol.374 (9), p.833-842</ispartof><rights>Copyright © 2016 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-a77a55ee9be39dbed40627f493b1683e193468b63af38679de8ba6c753b420373</citedby><cites>FETCH-LOGICAL-c456t-a77a55ee9be39dbed40627f493b1683e193468b63af38679de8ba6c753b420373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa1510795$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1770399029?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>315,782,786,2763,2764,26112,27933,27934,52391,54073,64394,64396,64398,72478</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26761625$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Armstrong, Gregory T</creatorcontrib><creatorcontrib>Chen, Yan</creatorcontrib><creatorcontrib>Yasui, Yutaka</creatorcontrib><creatorcontrib>Leisenring, Wendy</creatorcontrib><creatorcontrib>Gibson, Todd M</creatorcontrib><creatorcontrib>Mertens, Ann C</creatorcontrib><creatorcontrib>Stovall, Marilyn</creatorcontrib><creatorcontrib>Oeffinger, Kevin C</creatorcontrib><creatorcontrib>Bhatia, Smita</creatorcontrib><creatorcontrib>Krull, Kevin R</creatorcontrib><creatorcontrib>Nathan, Paul C</creatorcontrib><creatorcontrib>Neglia, Joseph P</creatorcontrib><creatorcontrib>Green, Daniel M</creatorcontrib><creatorcontrib>Hudson, Melissa M</creatorcontrib><creatorcontrib>Robison, Leslie L</creatorcontrib><title>Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>Alterations in treatment intensity and decreased use of radiation therapy have reduced the risk of late treatment-related death in long-term survivors of childhood cancer.
In the 1960s, fewer than half the children in whom cancer was diagnosed were still alive 5 years later.
1
Now, more than 83% of patients with a childhood cancer in the United States become 5-year survivors of the disease.
2
As a result, in 2013 it was estimated that there were more than 420,000 survivors of childhood cancer in the United States and that by the year 2020 this number would surpass 500,000.
3
Increased success in the treatment of childhood cancers has been achieved through the systematic conduct of clinical trials to assess the efficacy of multimodal approaches involving combination chemotherapy, . . .</description><subject>Acute lymphoblastic leukemia</subject><subject>Adolescent</subject><subject>Age of Onset</subject><subject>Anthracycline</subject><subject>Astrocytoma - mortality</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Child</subject><subject>Child mortality</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Children & youth</subject><subject>Clinical outcomes</subject><subject>Cohort Studies</subject><subject>Death</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Health risk assessment</subject><subject>Heart</subject><subject>Hodgkin Disease - mortality</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Lymphatic leukemia</subject><subject>Lymphoma</subject><subject>Male</subject><subject>Mortality</subject><subject>Mortality - trends</subject><subject>Neoplasms - mortality</subject><subject>Neoplasms - therapy</subject><subject>Patients</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality</subject><subject>Radiation therapy</subject><subject>Recurrence</subject><subject>Survivors</subject><subject>United States - epidemiology</subject><subject>Wilms Tumor - mortality</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10EtLw0AUBeBBFFurS7cyIIKb6EzmlVlKaH3QKvhYuAqT5MamJJk6kxT6701pFRS8m7v5OBwOQqeUXFEi5PXj-GFmDRWUKC320JAKxgLOidxHQ0LCKOBKswE68n5B-qNcH6JBKJWkMhRDNHmGvMva0ja4bPDUtIBn1rWmKts1NrVtPrAI3sE4_NK5VbmyzmNb4HheVvnc2hzHpsnAHaODwlQeTnZ_hN4m49f4Lpg-3d7HN9Mg40K2gVHKCAGgU2A6TyHve4aq4JqlVEYMqGZcRqlkpmCRVDqHKDUyU4KlPCRMsRG63OYunf3swLdJXfoMqso0YDufUKXCiFGleU_P_9CF7VzTt9sowrQmoe5VsFWZs947KJKlK2vj1gklyWbg5NfAvT_bpXZpDfmP_l60BxdbUNc-aWBR_xP0Bew-fzM</recordid><startdate>20160303</startdate><enddate>20160303</enddate><creator>Armstrong, Gregory T</creator><creator>Chen, Yan</creator><creator>Yasui, Yutaka</creator><creator>Leisenring, Wendy</creator><creator>Gibson, Todd M</creator><creator>Mertens, Ann C</creator><creator>Stovall, Marilyn</creator><creator>Oeffinger, Kevin C</creator><creator>Bhatia, Smita</creator><creator>Krull, Kevin R</creator><creator>Nathan, Paul C</creator><creator>Neglia, Joseph P</creator><creator>Green, Daniel M</creator><creator>Hudson, Melissa M</creator><creator>Robison, Leslie L</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20160303</creationdate><title>Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer</title><author>Armstrong, Gregory T ; Chen, Yan ; Yasui, Yutaka ; Leisenring, Wendy ; Gibson, Todd M ; Mertens, Ann C ; Stovall, Marilyn ; Oeffinger, Kevin C ; Bhatia, Smita ; Krull, Kevin R ; Nathan, Paul C ; Neglia, Joseph P ; Green, Daniel M ; Hudson, Melissa M ; Robison, Leslie L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-a77a55ee9be39dbed40627f493b1683e193468b63af38679de8ba6c753b420373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acute lymphoblastic leukemia</topic><topic>Adolescent</topic><topic>Age of Onset</topic><topic>Anthracycline</topic><topic>Astrocytoma - mortality</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Child</topic><topic>Child mortality</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Children & youth</topic><topic>Clinical outcomes</topic><topic>Cohort Studies</topic><topic>Death</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Health risk assessment</topic><topic>Heart</topic><topic>Hodgkin Disease - mortality</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Lymphatic leukemia</topic><topic>Lymphoma</topic><topic>Male</topic><topic>Mortality</topic><topic>Mortality - trends</topic><topic>Neoplasms - mortality</topic><topic>Neoplasms - therapy</topic><topic>Patients</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality</topic><topic>Radiation therapy</topic><topic>Recurrence</topic><topic>Survivors</topic><topic>United States - epidemiology</topic><topic>Wilms Tumor - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Armstrong, Gregory T</creatorcontrib><creatorcontrib>Chen, Yan</creatorcontrib><creatorcontrib>Yasui, Yutaka</creatorcontrib><creatorcontrib>Leisenring, Wendy</creatorcontrib><creatorcontrib>Gibson, Todd M</creatorcontrib><creatorcontrib>Mertens, Ann C</creatorcontrib><creatorcontrib>Stovall, Marilyn</creatorcontrib><creatorcontrib>Oeffinger, Kevin C</creatorcontrib><creatorcontrib>Bhatia, Smita</creatorcontrib><creatorcontrib>Krull, Kevin R</creatorcontrib><creatorcontrib>Nathan, Paul C</creatorcontrib><creatorcontrib>Neglia, Joseph P</creatorcontrib><creatorcontrib>Green, Daniel M</creatorcontrib><creatorcontrib>Hudson, Melissa M</creatorcontrib><creatorcontrib>Robison, Leslie L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Armstrong, Gregory T</au><au>Chen, Yan</au><au>Yasui, Yutaka</au><au>Leisenring, Wendy</au><au>Gibson, Todd M</au><au>Mertens, Ann C</au><au>Stovall, Marilyn</au><au>Oeffinger, Kevin C</au><au>Bhatia, Smita</au><au>Krull, Kevin R</au><au>Nathan, Paul C</au><au>Neglia, Joseph P</au><au>Green, Daniel M</au><au>Hudson, Melissa M</au><au>Robison, Leslie L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2016-03-03</date><risdate>2016</risdate><volume>374</volume><issue>9</issue><spage>833</spage><epage>842</epage><pages>833-842</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>Alterations in treatment intensity and decreased use of radiation therapy have reduced the risk of late treatment-related death in long-term survivors of childhood cancer.
In the 1960s, fewer than half the children in whom cancer was diagnosed were still alive 5 years later.
1
Now, more than 83% of patients with a childhood cancer in the United States become 5-year survivors of the disease.
2
As a result, in 2013 it was estimated that there were more than 420,000 survivors of childhood cancer in the United States and that by the year 2020 this number would surpass 500,000.
3
Increased success in the treatment of childhood cancers has been achieved through the systematic conduct of clinical trials to assess the efficacy of multimodal approaches involving combination chemotherapy, . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>26761625</pmid><doi>10.1056/NEJMoa1510795</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 2016-03, Vol.374 (9), p.833-842 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_proquest_miscellaneous_1772831794 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
subjects | Acute lymphoblastic leukemia Adolescent Age of Onset Anthracycline Astrocytoma - mortality Cancer Cancer therapies Child Child mortality Child, Preschool Children Children & youth Clinical outcomes Cohort Studies Death Disease Progression Female Health risk assessment Heart Hodgkin Disease - mortality Humans Incidence Infant Lymphatic leukemia Lymphoma Male Mortality Mortality - trends Neoplasms - mortality Neoplasms - therapy Patients Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality Radiation therapy Recurrence Survivors United States - epidemiology Wilms Tumor - mortality |
title | Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-29T01%3A51%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduction%20in%20Late%20Mortality%20among%205-Year%20Survivors%20of%20Childhood%20Cancer&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Armstrong,%20Gregory%20T&rft.date=2016-03-03&rft.volume=374&rft.issue=9&rft.spage=833&rft.epage=842&rft.pages=833-842&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMoa1510795&rft_dat=%3Cproquest_cross%3E1772831794%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1770399029&rft_id=info:pmid/26761625&rfr_iscdi=true |